Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology. Berlin: Springer, 2004., ,
Quantitative MRI of the Brain: Measuring Changes Caused by Disease. New York: Wiley, 2003.
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32., , , et al.
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005;92:1599–610., , , et al.
Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357–67.,
Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer. Magn Reson Med 2011; 66: 219–26., , , et al.
Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT.Magn Reson Med 2010;63:1601–9., , , et al.
Ni-DTPA doped agarose gel–a phantom material for Gd-DTPA enhancement measurements. Magn Reson Imaging 1993;11:125–33., ,
The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Magn Reson Imaging 1996;14:243–53., , ,
Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med 2000;44:665–7.,
Water proton MR properties of human blood at 1.5 Tesla: magnetic susceptibility, T(1), T(2), T*(2), and non-Lorentzian signal behavior. Magn Reson Med 2001;45:533–42., , ,
Medical Physiology. Philadelphia: Saunders, 2008.,
Proc Intl Soc Magn Reson Med, Montreal, Canada, 2011; 1078., , , et al. Individually Measured Hematocrit in DCE-MRI studies.
Kinetics of distribution of substances admitted to the body. I. The extravascular modes of administration. Arch Int Pharmacodyn Ther 1937;57:205–25.
The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951;3:1–41.
Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16:167–72., ,
Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006;56:993–1000., , ,et al.
A functional form for injected MRI Gd-chelate contrast agent concentration incorporating recirculation, extravasation and excretion. Phys Med Biol 2009;54:2933–49., , , et al.
Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91–101.
On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2011;66:735–45.,
Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability. Phys Med Biol 2012; 57:R1–33.,
Generalization of the Fahraeus principle for microvessel networks. Am J Physiol 1986;251:H1324–32., ,
Small vessel and total coronary blood volume during intracoronary adenosine. Am J Physiol 1981;241:H194–201., ,
Regional cerebral blood volume and hematocrit measured in normal human volunteers by single-photon emission computed tomography. J Cereb Blood Flow Metab 1985;5:207–13., , , et al.
Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637–41., , , et al.
Flow of blood through narrow capillaries: rheological mechanisms determining capillary hematocrit and apparent viscosity. Biorheology 1980;17:183–9.
Proc Intl Soc Magn Reson Med, Stockholm, Sweden, 2010; 326., , , Accurate and precise measurement of renal filtration and vascular parameters using DCE-MRI and a 3-compartment model.
Precise measurement of renal filtration and vascular parameters using a two-compartment model for dynamic contrast-enhanced MRI of the kidney gives realistic normal values. Eur Radiol 2012;22:1320–30., , , ,
An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18:1365–77.,
A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix. Magn Reson Med 2010;63:691–700., , , et al.
Quantitative assessment of pulmonary perfusion with dynamic contrast-enhanced MRI.Magn Reson Med 1999;42:1033–8., , , et al.
Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects. J Magn Reson Imaging 2004;20:353–65., , , et al.
Quantification of myocardial perfusion by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:57.
Modeling of contrast agent kinetics in the lung using T1-weighted dynamic contrast-enhanced MRI. Magn Reson Med 2009;61:1507–14., , , et al.
Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 2004;52:420–9., , , et al.
Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn Reson Med 2009;62:205–17., , , ,
Pharmacokinetic analysis of tissue microcirculation using nested models: multimodel inference and parameter identifiability. Med Phys 2009;36:2923–33., , ,
A model for capillary exchange. Am J Physiol 1966;210:1299–303.,
The inclusion of capillary distribution in the adiabatic tissue homogeneity model of blood flow. Phys Med Biol 2001;46:1519–38., , , et al.
Quantitative MRI of the Brain: Measuring Changes Caused by Disease. Chichester: John Wiley, 2003;55–81.QA: quality assurance, accuracy, precision and phantoms. In: , editor,
Tracer kinetic model-driven registration for dynamic contrast-enhanced MRI time-series data. Magn Reson Med 2007;58:1010–19., , , et al.
Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 1998;16:1057–73., ,
Prebolus quantitative MR heart perfusion imaging. Magn Reson Med 2004;52:296–9., , , et al.
Dual-bolus approach to quantitative measurement of pulmonary perfusion by contrast-enhanced MRI. J Magn Reson Imaging 2006;24:1284–90., , ,
Phase-based arterial input function measurements in the femoral arteries for quantification of dynamic contrast-enhanced (DCE) MRI and comparison with DCE-CT. Magn Reson Med 2011; 66:1267–74., , , et al.
Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging 2005;23:519–29., , , et al.
The effect of blood inflow and B(1)-field inhomogeneity on measurement of the arterial input function in axial 3D spoiled gradient echo dynamic contrast-enhanced MRI. Magn Reson Med 2011;65:108–19., , , et al.
Measurement of single kidney function using dynamic contrast-enhanced MRI: comparison of two models in human subjects. J Magn Reson Imaging 2006;24:1117–23., , , et al.
A simple method for investigating the effects of non-uniformity of radiofrequency transmission and radiofrequency reception in MRI. Br J Radiol 1998;71:59–67., , ,
Accuracy of T1 measurement in dynamic contrast-enhanced breast MRI using two- and three-dimensional variable flip angle fast low-angle shot. J Magn Reson Imaging 1999;9:163–71., , , ,
Accurate multislice gradient echo T(1) measurement in the presence of non-ideal RF pulse shape and RF field nonuniformity. Magn Reson Med 2001;45:838–45., ,
Fast, accurate, and precise mapping of the RF field in vivo using the 180 degrees signal null. Magn Reson Med 2007;58:622–30.,
Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995;33:564–8., ,
Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996;36:225–31., , , , ,
Enhancing fraction predicts clinical outcome following first-line chemotherapy in patients with epithelial ovarian carcinoma. Clin Cancer Res 2007;13:6130–5., , ,et al.
Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix. Br J Cancer 2010;102:23–6., , , et al.
Tumour enhancing fraction (EnF) in glioma: relationship to tumour grade. Eur Radiol 2009;19:1489–98., , , et al.
Model selection for DCE-T1 studies in glioblastoma. Magn Reson Med 2011;68:241–51., , , et al.
Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter maps. Magn Reson Med 2009;62:488–99., , , et al.
Characterization of image heterogeneity using 2D Minkowski functionals increases the sensitivity of detection of a targeted MRI contrast agent. Magn Reson Med 2009;61:1218–24., , , et al.
Quantitative MRI of the Brain: Measuring Changes Caused by Disease. Chichester: John Wiley, 2003;581–610., , Histograms: measuring subtle diffuse disease. In: , editor.
Quantitative analysis of whole-tumor Gd enhancement histograms predicts malignant transformation in low-grade gliomas. J Magn Reson Imaging 2007;25:208–14., , , et al.
Analysis of MTR histograms in multiple sclerosis using principal components and multiple discriminant analysis. Magn Reson Med 2001;46:600–9., , , et al.
2011; 27. Fast modelling of slow DCE data from prostate: rate constant (kep) and extracellular extravascular space (EES: ve) both distinguish hypoxic regions in the tumour. European Society for Magnetic Resonance in Medicine and Biology Congress Leipzig
Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging–initial experience. Radiology 2004;233:709–15., , , ,
Changes underlying the dynamic contrast-enhanced MRI response to treatment in rheumatoid arthritis. Skeletal Radiol 2008;37:201–7., , , et al.